Circulating levels of insulin-like growth factor-I and risk of ovarian cancer - Wikidata - wikimedia - TriplyDB

Circulating levels of insulin-like growth factor-I and risk of ovarian cancer

Circulating levels of insulin-like growth factor-I and risk of ovarian cancer

http://www.wikidata.org/entity/Q57037912

about

Gene expression profiling of epithelial ovarian tumours correlated with malignant potential The insulin-like growth factor system in cancer Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women.Targeting insulin and insulin-like growth factor pathways in epithelial ovarian cancer Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.Insulin-like growth factor-I and cancer mortality in older men.Cancer, physical activity, and exercise Vegetarian diets and the incidence of cancer in a low-risk population.Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.Insulin-like growth factors and neoplasia.Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy.IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control study Associations between Fatness, Fitness, IGF and IMT among Obese Korean Male Adolescents.Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: A systematic review and meta-analysis GSK1838705A, an IGF-1R inhibitor, inhibits glioma cell proliferation and suppresses tumor growth in vivo.The insulin and igf-I pathway in endocrine glands carcinogenesis High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation.Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies.Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies.Placental weight and risk of invasive epithelial ovarian cancer with an early age of onset Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort Impact of targeting insulin-like growth factor signaling in head and neck cancers.Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender.Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.Targeting IGF-1 signaling pathways in gynecologic malignancies.Lycopene-derived bioactive retinoic acid receptors/retinoid-X receptors-activating metabolites may be relevant for lycopene's anti-cancer potential.Dairy consumption and gastric cancer risk: a meta-analysis of epidemiological studies.Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium.Obesity and Ovarian Cancer.Calcium Intake and the Risk of Ovarian Cancer: A Meta-Analysis.Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer.Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer.Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.Is body size associated with ovarian cancer in southern Chinese women?Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer.Ovarian cancer in obese women: risk and optimal medical and surgical treatment options.

P2860

Q24805553-D8AC6787-30FE-4F08-8EAF-7176C4795242 Q27013945-201A6303-5D31-449B-893B-12EDD8FE0BA6 Q30353949-D9492805-2557-4BB7-86A2-27DAB04B1AF5 Q33581021-737B831E-A488-43DA-B85F-C494AB217EA5 Q33725701-D8C80FF6-BBB7-4513-94C4-071FBE623183 Q33738660-72922F8E-1A11-49A6-9984-F57C524205E2 Q34004946-711DDD2E-79A1-45CD-ABD4-F25982E8DD2B Q34034471-A30D0269-B0CC-4DF2-9070-CEEE3053CF93 Q34328099-CE465125-26BF-46E1-B47E-0FF5A89FB7F9 Q34330521-7FDC3F06-5672-4CFF-B533-7F2D17E81A43 Q34539063-09A1FABC-FAAE-429E-B538-9C81AE1207F9 Q34556695-C1DC2CD7-30FC-4D8A-8D00-B14F33E44F43 Q34955369-9F5724C4-B64A-42E6-800F-D4F74D9A2897 Q35598117-01C2569D-AAF1-495B-B104-96FEE50C8377 Q35661444-43E4DDA4-09D9-4C86-BF2E-DFD84A942D08 Q35677731-C1CBBB2D-7606-43B4-9640-1E7AA2376E3C Q35753660-B2B834FE-A77A-499E-91E7-517DACAD2A09 Q36089874-EA93A0C7-589E-4864-87F8-6FA3F2503F83 Q36178421-BBBECD42-3F2D-4314-AFBF-AFEEC669FA2B Q36354166-9EFD2CB6-C402-40D7-929B-95C437B9FE3E Q36611567-2ED88580-B11F-4AEB-BE27-90980E6887A8 Q36947246-CD5E6380-38F5-438A-9C33-14212DA35E05 Q37098077-1661E043-D544-47E2-9262-FC17B646D840 Q37105541-31725A83-B675-406B-86F8-44B0C2FE5E35 Q37126107-79CF5719-5804-414E-898C-24225B11CD10 Q37378287-1C7E2F46-5492-46A4-97E1-9E81CDD99B5A Q37452399-5853A8BB-2F69-40BE-9136-43B2477F9669 Q37472152-B59155ED-6E43-4841-9B82-66A136834F33 Q38072115-00A86B18-9D96-4212-8006-5D0FF884CCB2 Q38078872-542232EE-1EA0-4474-8E91-5713626A70D9 Q38449188-2A8CB9C0-E6FB-4D98-9319-BD7E8A2773DB Q38756834-F71650E3-D1DE-4891-B723-D95DBD994BAD Q38788240-70F8D5EB-4BE9-4F24-86C0-F04BF1BFF4F3 Q39406931-D312022E-183C-4D21-AB1A-395545CBD545 Q41601838-7BF66A69-6C2A-48AB-986A-D83B6FD3A07B Q44818446-8574365D-3A8B-4E1D-9226-7C31F732A09A Q46706696-5B1ACF14-30AF-469A-90AD-F7DC28D38C0A Q47279238-7D80AABB-B5F3-4811-A35E-2F43D9B2EA65 Q52659536-4C4F9508-DB4E-4F43-9A65-227439300118 Q53457611-67600872-4CEC-4669-827B-4CF5D96A1CFB

P2860

Circulating levels of insulin-like growth factor-I and risk of ovarian cancer

http://www.wikidata.org/entity/Q57037912

description

im September 2002 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2002

@uk

name

Circulating levels of insulin-like growth factor-I and risk of ovarian cancer

@en

Circulating levels of insulin-like growth factor-I and risk of ovarian cancer

@nl

type

label

Circulating levels of insulin-like growth factor-I and risk of ovarian cancer

@en

Circulating levels of insulin-like growth factor-I and risk of ovarian cancer

@nl

prefLabel

Circulating levels of insulin-like growth factor-I and risk of ovarian cancer

@en

Circulating levels of insulin-like growth factor-I and risk of ovarian cancer

@nl

P1433

Q57037912-A0EA3687-C0E0-4C9A-A155-6CD1487E5017

P1476

Q57037912-94EA65B8-D008-4A02-9032-33E4B1EE8B34

P2093

Q57037912-04564932-9AD3-496F-8A0D-9E1AD14F1A61

Q57037912-3AA74750-F281-43BB-BE36-80AC0C9E3DC8

Q57037912-3B2748C6-41C6-4F54-8DD0-5C6AE0E9EF2D

Q57037912-4AEFEA71-612E-4142-80E9-FCE3367B2617

Q57037912-A293A656-84A9-4019-B36E-072ED3453CCE

Q57037912-F485B0F1-1FD0-40E6-91D9-EEE47DB5FCCF

P2860

Q57037912-09441E9C-FB0F-4C53-8F77-82B330D15FE1

Q57037912-1A09E64B-828B-405B-9DEB-F48D84B32DFB

Q57037912-1FF0859B-0DDE-4F26-9521-587AD58939F3

Q57037912-4B42A4E2-D0FC-4621-82AC-E07320A19440

Q57037912-58CEC737-BF2C-4FC5-B1AD-1173CCD904D3

Q57037912-6EA34CAB-5C6C-4EB6-825D-0B9ABAC20D3C

Q57037912-706ACBBB-72EA-4F9E-8B50-9FCDC88DAB62

Q57037912-77A238EE-B6D8-492A-BC8D-9C0201BBF49C

Q57037912-7F8EDDAD-DD44-4F26-8826-2B12DE8F040D

Q57037912-8DDFC314-9355-4E3A-B9E1-1E763DF62CB4

P304

Q57037912-8350A05A-1362-43CB-AD12-0BBFAD419E8C

P31

Q57037912-3703A325-A5DB-459D-9458-B9FE19B3145F

P356

Q57037912-670720C2-00EA-4D44-AADC-A2581742E4A7

P433

Q57037912-D0E270AE-26EA-4F83-8C5E-0A526B014D83

P478

Q57037912-E5FF7BC7-D16A-45E6-AA52-A244A8BBFBC2

P50

Q57037912-1EB352CB-DE0D-42ED-B4FF-471CBE4DE2BC

Q57037912-3426178D-5D6D-495B-B372-4FE6A81C0F46

Q57037912-34D8DA56-7EB6-4E6C-B4B4-9CDCF284D445

Q57037912-592230B0-7ABE-4055-8E1E-4B52640464B6

Q57037912-6DF802C4-455B-440E-85EC-FEE4736549D3

Q57037912-7F9D7017-9E40-4D6A-9C07-D07964BC0CED

Q57037912-9CB777C1-58DF-4C3B-9956-72FD9E36491C

Q57037912-B579A2FD-132E-4C32-8A77-C66454C58D2C

Q57037912-EF1E7530-002C-47A1-A427-E0506F1D5988

P577

Q57037912-108E2394-D142-4D58-A8A4-7EEAA98819A7

P698

Q57037912-02F33819-591A-4E77-A0A7-013ED15A217C

P921

Q57037912-6D986556-9E37-416B-ACB7-A427FAD9EDD3

Q57037912-8EAE0D05-D316-438B-B80D-4E608C4294A7

Q57037912-D64C1956-4A14-4659-8F8D-FE209CD645FE

P356

P1433

International Journal of Cancer

P1476

Circulating levels of insulin-like growth factor-I and risk of ovarian cancer

@en

P2093

Arslan Akhmedkhanov

http://www.w3.org/2001/XMLSchema#string

Carine Biessy

http://www.w3.org/2001/XMLSchema#string

Franco Berrino

http://www.w3.org/2001/XMLSchema#string

G�ran Hallmans

http://www.w3.org/2001/XMLSchema#string

Paola Muti

http://www.w3.org/2001/XMLSchema#string

Paolo Toniolo

http://www.w3.org/2001/XMLSchema#string

P2860

Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden

Insulin-like growth factor type I increases concentrations of messenger ribonucleic acid encoding cytochrome P450 cholesterol side-chain cleavage enzyme in primary cultures of porcine granulosa cells.

Possible role of ovarian epithelial inflammation in ovarian cancer.

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.

Role of the insulin-like growth factor family in cancer development and progression.

Incessant ovulation--a factor in ovarian neoplasia?

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

Human ovarian surface epithelial (OSE) cells express LH/hCG receptors, and hCG inhibits apoptosis of OSE cells via up-regulation of insulin-like growth factor-1.

Insulin-like growth factor-I-mediated amplification of follicle-stimulating hormone-supported progesterone accumulation by cultured rat granulosa cells: enhancement of steroidogenic enzyme activity and expression.

P304

549-554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.10613

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Anne Zeleniuch-Jacquotte

Annekatrin Lukanova

P577

2002-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12237896

http://www.w3.org/2001/XMLSchema#string

P921

cancer research